Raf/MEK/ERK pathway dysregulation is associated with cancer oncogenesis, as evidenced by the facilitation of tumor proliferation, survival, invasion, metastasis, extracellular matrix degradation, and angiogenesis. This evidence concerns the gene RAF1 and cancer.